The Women's Hospital School of Medicine Zhejiang University is a hospital specialized for women in Hangzhou, Zhejiang Province, People's Republic of China.

During the past decade, Women's Hospital School Of Medicine Zhejiang University conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 6 clinical trials were completed, i.e. on average, 14% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 5 clinical trials were completed. i.e. 17.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Women's Hospital School Of Medicine Zhejiang University" #1 sponsor was "Women's Hospital School Of Medicine Zhejiang University" with 19 trials, followed by "Bayer" with 3 trials sponsored, "Ding Ma" with 3 trials sponsored, "Ipsen" with 3 trials sponsored and "Akeso" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Women's Hospital School Of Medicine Zhejiang University" #1 collaborator was "Shandong University" with 4 trials as a collaborator, "Zhejiang University" with 4 trials as a collaborator, "Huazhong University of Science and Technology" with 3 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator and "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Women's Hospital School Of Medicine Zhejiang University" are "Cervical Cancer" (5 trials), "Cervical Intraepithelial Neoplasia" (4 trials), "Endometrial Neoplasms" (4 trials), "Endometriosis" (4 trials) and "Infertility" (3 trials). Many other conditions were trialed in "Women's Hospital School Of Medicine Zhejiang University" in a lesser frequency.

Most popular intervention types in "Women's Hospital School Of Medicine Zhejiang University" are "Drug" (36 trials), "Other" (12 trials), "Procedure" (6 trials), "Biological" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Paclitaxel" (6 trials), "Carboplatin" (4 trials), "AK104" (2 trials) and "Lenvatinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Women's Hospital School Of Medicine Zhejiang University" are 52 trials for "Female" genders and 4 trials for "All" genders.

Currently, there are NaN active trials in "Women's Hospital School Of Medicine Zhejiang University". 4 are not yet recruiting, 18 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Women's Hospital School Of Medicine Zhejiang University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Women's Hospital School Of Medicine Zhejiang University, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 9 trials that are defined as “Not Applicable".